Provenance du réseau au premier degré de Nathan Alan Smith
Entité | Type d'entité | Industrie | |
---|---|---|---|
Myriad GmbH
Myriad GmbH Medical/Nursing ServicesHealth Services Part of Myriad Genetics, Inc., Myriad GmbH is a German company that provides health care services. The company is based in Munich, Germany. The CEOs of the company are Nathan Alan Smith, Peter D. Meldrum, Raymond Francot.
2
| Subsidiary | Medical/Nursing Services | 2 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Nathan Alan Smith via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
MYRIAD GENETICS, INC. | Medical Specialties | Founder | |
The Founders Fund, Inc.
The Founders Fund, Inc. Miscellaneous Commercial ServicesCommercial Services The Founders Fund, Inc. provides financial assistance to students. It offers scholarships and sponsoring solutions to students for them to defray the cost of attending colleges, universities, and professional programs. The company was founded in 1991 and is headquartered in Naples, FL. | Miscellaneous Commercial Services | President | |
SINTX TECHNOLOGIES, INC. | Medical Specialties | Director/Board Member | |
University of Utah | College/University | Masters Business Admin | |
Westminster College (Utah) | College/University | Doctorate Degree | |
Prolexys Pharmaceuticals, Inc.
Prolexys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Prolexys Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering small molecule drugs that act at novel therapeutic targets. The Company's therapeutic focus is on cancer and cardiovascular indications. Prolexys scientists have exploited proprietary proteomics-related techniques to rapidly and accurately identify drug candidates that interact with targets of interest. The result of targeted drug discovery work at Prolexys is a pipeline of product candidates with high value in areas of unmet medical need. Lead programs include: a) Solid tumor oncology program with a small molecule clinical candidate with selective anti-tumor activity, b) The colon cancer program with novel small molecule compounds targeting the beta-catenin signaling cascade and c) HSP20 antagonists, identified as protein interaction inhibitors from targets validated in asthma and vasorelaxation. | Pharmaceuticals: Major | Director/Board Member | |
ENDOCYTE, INC. | Pharmaceuticals: Major | Director/Board Member | |
Myriad Service GmbH
Myriad Service GmbH Medical/Nursing ServicesHealth Services Part of Myriad Genetics, Inc., Myriad Service GmbH provides healthcare services. The company is based in Planegg, Germany. The CEOs of the German company are Nathan Man Smith, Raymond Francot. | Medical/Nursing Services | Chief Executive Officer |
Statistiques
Internationale
Etats-Unis | 8 |
Allemagne | 2 |
Sectorielle
Health Technology | 5 |
Consumer Services | 3 |
Commercial Services | 2 |
Health Services | 2 |
Opérationnelle
Director/Board Member | 4 |
Chief Executive Officer | 4 |
President | 2 |
Doctorate Degree | 2 |
Founder | 1 |
Relations les plus connectées
Insiders | |
---|---|
Peter D. Meldrum | 8 |
Raymond Francot | 2 |
- Bourse
- Insiders
- Nathan Alan Smith
- Connexions Sociétés